These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30737795)

  • 21. Association of Diaphragmatic Surgery as Part of Cytoreductive Effort in Advanced Stage Ovarian Cancer.
    Bacalbasa N; Balescu I; Balalau C; Ionescu O; Stoica C
    In Vivo; 2018; 32(2):431-436. PubMed ID: 29475933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laparoscopy for primary cytoreduction with multivisceral resections in advanced ovarian cancer: prospective validation. "The times they are a-changin"?
    Ceccaroni M; Roviglione G; Bruni F; Clarizia R; Ruffo G; Salgarello M; Peiretti M; Uccella S
    Surg Endosc; 2018 Apr; 32(4):2026-2037. PubMed ID: 29052073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Prognostic Role of Optimal Cytoreduction in Advanced, Bowel Infiltrating Ovarian Cancer.
    Bachmann R; Rothmund R; Krämer B; Brucker SY; Königsrainer A; Königsrainer I; Beckert S; Staebler A; NguyenHuu P; Grischke E; Wallwiener D; Bachmann C
    J Invest Surg; 2015 Jun; 28(3):160-6. PubMed ID: 25565126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome.
    Bristow RE; Peiretti M; Gerardi M; Zanagnolo V; Ueda S; Diaz-Montes T; Giuntoli RL; Maggioni A
    Gynecol Oncol; 2009 Aug; 114(2):173-7. PubMed ID: 19482344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The place of bowel resection in initial debulking surgery for advanced ovarian cancer.
    Miller J; Proietto A
    Aust N Z J Obstet Gynaecol; 2002 Nov; 42(5):535-7. PubMed ID: 12495103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended left colon resections as part of complete cytoreduction for ovarian cancer: tips and considerations.
    Silver DF; Bou Zgheib N
    Gynecol Oncol; 2009 Sep; 114(3):427-30. PubMed ID: 19555997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of Anastomotic Leakage in Ovarian Cancer Debulking Surgery and Its Impact on Overall Survival.
    Koscielny A; Ko A; Egger EK; Kuhn W; Kalff JC; Keyver-Paik MD
    Anticancer Res; 2019 Sep; 39(9):5209-5218. PubMed ID: 31519635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bowel Resection Outcomes in Ovarian Cancer Cytoreductive Surgery by Surgeon Specialty.
    Ebott J; Has P; Raker C; Robison K
    JAMA Surg; 2024 Oct; 159(10):1188-1194. PubMed ID: 39110445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morbidity of rectosigmoid resection in cytoreductive surgery for ovarian cancer. Risk factor analysis.
    Fournier M; Huchon C; Ngo C; Bensaid C; Bats AS; Combe P; le FrèreBelda MA; Fournier L; Berger A; Lecuru F
    Eur J Surg Oncol; 2018 Jun; 44(6):750-753. PubMed ID: 29580734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical observation of partial pancreatectomy as part of primary cytoreductive surgery in advanced epithelial ovarian cancer].
    Xiang LB; Tu YX; He TC; Pei X; Shen XX; Yang WT; Wu XH; Yang HJ
    Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):361-5. PubMed ID: 27256444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer.
    Eng OS; Raoof M; Blakely AM; Yu X; Lee SJ; Han ES; Wakabayashi MT; Yuh B; Lee B; Dellinger TH
    J Surg Oncol; 2018 Jul; 118(1):121-126. PubMed ID: 29878375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome.
    Bristow RE; Peiretti M; Zanagnolo V; Salani R; Giuntoli RL; Maggioni A
    Gynecol Oncol; 2008 Jun; 109(3):364-9. PubMed ID: 18396322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of optimal debulking surgery with bowel resection in patients with advanced ovarian cancer.
    Derlatka P; Sienko J; Grabowska-Derlatka L; Palczewski P; Danska-Bidzinska A; Bidzinski M; Czajkowski K
    World J Surg Oncol; 2016 Feb; 14():58. PubMed ID: 26923029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended-duration antibiotics are not associated with a reduction in surgical site infection in patients with ovarian cancer undergoing cytoreductive surgery with large bowel resection.
    Chalif J; Chambers LM; Yao M; Kuznicki M; DeBernardo R; Rose PG; Michener CM; Vargas R
    Gynecol Oncol; 2024 Jul; 186():161-169. PubMed ID: 38691986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of bowel surgery with cytoreduction for epithelial ovarian cancer.
    Cai HB; Zhou YF; Chen HZ; Hou HY
    Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):757-62. PubMed ID: 17889517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of pre-existent bacterial colonization in patients with advanced/relapsed ovarian neoplasms undergoing cytoreductive surgery: a multicenter observational study (BONSAI).
    Fotopoulou C; Rinne N; Ghirardi V; Cunnea P; Drosou A; Tzovaras D; Giudice MT; Scambia G; Fagotti A
    Int J Gynecol Cancer; 2020 Oct; 30(10):1562-1568. PubMed ID: 32817201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The NICE classification for 'Ultra-radical (extensive) surgery for advanced ovarian cancer' guidance does not meaningfully predict postoperative complications: a cohort study.
    Phillips A; Sundar S; Singh K; Pounds R; Nevin J; Kehoe S; Balega J; Elattar A
    BJOG; 2019 Jan; 126(1):96-104. PubMed ID: 30092615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rectosigmoid resection at the time of primary cytoreduction for advanced ovarian cancer. A multi-center analysis of surgical and oncological outcomes.
    Peiretti M; Bristow RE; Zapardiel I; Gerardi M; Zanagnolo V; Biffi R; Landoni F; Bocciolone L; Aletti GD; Maggioni A
    Gynecol Oncol; 2012 Aug; 126(2):220-3. PubMed ID: 22555105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Extended Primary Surgery on Suboptimally Operable Patients With Advanced Ovarian Cancer.
    Oseledchyk A; Hunold LE; Mallmann MR; Domröse CM; Abramian A; Debald M; Kaiser C; Kiefer N; Putensen C; Pantelis D; Fimmers R; Kuhn W; Schäfer N; Keyver-Paik MD
    Int J Gynecol Cancer; 2016 Jun; 26(5):873-83. PubMed ID: 27101586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Western Australian experience of the use of en bloc resection of ovarian cancer with concomitant rectosigmoid colectomy.
    Clayton RD; Obermair A; Hammond IG; Leung YC; McCartney AJ
    Gynecol Oncol; 2002 Jan; 84(1):53-7. PubMed ID: 11748976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.